Cowan D F
Department of Pathology, State University of New York, Buffalo.
Arch Pathol Lab Med. 1990 Feb;114(2):129-34.
Quality assurance (QA) is the outcome-oriented process by which the performance of a complex production operation is evaluated. It is strongly focused on the use of resources and the end product, and is closely related to marketing. The pathologist's product is information, and the practice of anatomic pathology is evaluated as a system for producing and effectively communicating information. Our integrated program for QA in surgical pathology, autopsy pathology, and cytopathology recognizes that several discrete elements make up the sequence leading to communication of the diagnostic opinion. These are control and processing of the specimen, accuracy of diagnosis, timely and clear communication, efficiency in production of information, coherence with institutional programs in QA, and relation to licensing and accreditation agencies. Each of these elements may be tested separately and sources of error reduced so that the validity and cost of the pathologist's prediction will ultimately be limited only by the state of the art and not by any failure of the information system. Several components of QA, especially resource utilization by pathologists, are potentially productive areas for operations research.
质量保证(QA)是一个以结果为导向的过程,通过该过程来评估复杂生产操作的绩效。它高度关注资源的使用和最终产品,并且与市场营销密切相关。病理学家的产品是信息,而解剖病理学实践被视为一个产生并有效传达信息的系统来进行评估。我们针对外科病理学、尸检病理学和细胞病理学的综合质量保证计划认识到,有几个离散的要素构成了通向诊断意见传达的序列。这些要素包括标本的控制与处理、诊断的准确性、及时且清晰的沟通、信息生成的效率、与机构质量保证计划的一致性以及与许可和认证机构的关系。这些要素中的每一个都可以单独进行测试,并且减少误差来源,以便病理学家预测的有效性和成本最终仅受现有技术水平的限制,而不受信息系统任何故障的影响。质量保证的几个组成部分,尤其是病理学家的资源利用,是运筹学潜在的富有成效的领域。